Neuroone Medical Technologies CORP (NMTC) — 10-Q Filings

All 10-Q filings from Neuroone Medical Technologies CORP. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

NeuroOne's Revenue Soars 99.8%, Narrows Loss on Strong Product Sales — Aug 14, 2025 Risk: medium
NEUROONE MEDICAL TECHNOLOGIES Corp reported a significant increase in product revenue for the nine months ended June 30, 2025, reaching $6,356,767, a 99.8% incr
NeuroOne Medical Technologies Files Q1 2025 10-Q — May 13, 2025 Risk: low
NeuroOne Medical Technologies Corp. filed its 10-Q for the quarterly period ended March 31, 2025. The company, incorporated in Delaware with its principal execu
NeuroOne Medical Technologies Files Q3 2024 10-Q — Feb 12, 2025 Risk: medium
NeuroOne Medical Technologies Corporation filed its 10-Q for the quarterly period ended December 31, 2024. The company, incorporated in Delaware with its princi
NeuroOne Medical Technologies Files Q2 2024 10-Q — Aug 14, 2024 Risk: low
NeuroOne Medical Technologies Corporation filed its 10-Q for the quarterly period ended June 30, 2024. The company, incorporated in Delaware, operates in the su
NeuroOne Medical Technologies Corp Files 10-Q for Period Ended March 31, 2024 — May 14, 2024 Risk:
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. NeuroOne Medical Technologies Corporation filed a 10-Q r
NeuroOne Medical Technologies Corp. Files 10-Q for Period Ended December 31, 2023 — Feb 13, 2024 Risk: low
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) filed a Quarterly Report (10-Q) with the SEC on February 13, 2024. NeuroOne Medical Technologies Corporation filed a 1

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX